This webinar will dive into the latest developments regarding COVID-19 in the context of pulmonary fibrosis. We'll discuss the current landscape of the pandemic, explore updated vaccine information, and examine the impact of the virus on patients with ILD and lung transplant recipients. Additionally, we'll touch on post-COVID pulmonary fibrosis and strategies for monitoring and treatment. Join us for this essential update tailored for our community.

Sponsored with the generous support of Boehringer Ingelheim, Genentech, a member of the Roche Group, and United Therapeutics.

Social media platforms -
Twitter - @PFFORG
Facebook - @PFFORG
Instagram - @PFFORG
LinkedIn- Pulmonary Fibrosis Foundation

Please note that any information contained in this presentation is for informational and/or educational purposes only. It is not intended to be a substitute for professional medical advice. Always consult your personal physician or health care provider with any questions you may have regarding your specific medical condition.


This presentation is protected by U.S. and International copyright laws. Reproduction and distribution of this presentation without written permission from the Pulmonary Fibrosis Foundation is prohibited.


© 2023 Pulmonary Fibrosis Foundation